Notably, MDA-MB-231 and CAL-51 cells displayed significantly prolonged mitotic duration compared to MCF10A and RPE1 cells (Figure 2A–C and Figure 2—figure supplement 1A–C), indicating greater sensitivity of breast cancer cells to CMPD1 treatment relative to normal cells. This evidence concerns the gene SOX9 and breast cancer.